Initial Encounter
Maribel Gonzalez, MS, ARNP, FNP-C
This session will provide a review of the components of initial patient encounter with the healthcare provider which can be one of the most important health visits for the patient. There are a variety of issues that need to be addressed at this visit including education of the patient regarding HIV, general health maintenance, and support services available. Additionally, a full history and physical are completed and baseline laboratory data are obtained. The data obtained at the initial visit will provide valuable information to direct the future care of the patient. 
(Handouts)

Prevention of OIs and Immunizations in HIV Infected Adults
Don Kurtyka, ARNP, PhD
Prevention is an integral component of HIV care in the era of highly active antiretroviral therapy. This session will review the indications for initiating prophylaxis of opportunistic infections associated with HIV disease including appropriate agents and clinical indications. Additionally, vaccines used in caring for HIV-infected patients will be discussed including clinical indications, administration, and efficacy.
(Handouts)

Management of the ARV-naïve Patient
Jennifer Janelle, MD
There are several factors that need to be considered when designing an initial regimen for an antiretroviral-naïve patient. This session will provide a patient case-based overview of the initial regimen selection including: timing of initiation of therapy, preferred and alternative regimens according to the most recent DHHS guidelines, consideration of co-morbid conditions and other patient factors, and indications for changing therapy.
(Handouts)

HIV and TB
Michael Lauzardo, MD
Tuberculosis remains a leading cause of death among HIV-infected patients worldwide. Annual screening for latent tuberculosis infection remains an important recommended prevention strategy in HIV-infected individuals. Diagnosing and treating active tuberculosis in HIV-infected individuals can be challenging due to the often atypical presentation and drug-drug interactions among anti-TB and HIV therapies. This session will utilize cases to review screening and treatment of latent tuberculosis infection, clinical presentation of active tuberculosis disease, and treatment of active tuberculosis.  
(Handouts)

Complications of ARV Therapy
Jose Montero, MD
As people infected with HIV are living longer as a result of receiving antiretroviral therapy, certain complications related to antiretroviral therapy have been recognized. This session will describe the common adverse effects associated with antiretroviral use and discuss strategies to minimize their risk and manage their consequences. 
(Handouts)

Drug Interactions
Joanne Orrick, PharmD, AAHIVE
Due to continued advances in antiretroviral therapy, HIV-infected patients have an increased life-span. Patients are on multiple medications both for treatment and prevention of opportunistic diseases and treatment of co-morbid conditions. Identifying and managing drug-drug interactions can be challenging. This session will provide a case-based review of the most common and severe potential drug-drug interactions encountered in patients receiving antiretroviral therapy.
(Handouts)

Hepatitis Co-infection
Jeffrey Beal, MD, AAHIVS
Hepatitis B and C infection within the HIV infected population is emerging as a leading cause of increased morbidity and mortality among our patients. This session will discuss the diagnosis and management within our HIV practices of the Hepatitis coinfected patient. Decision-making as to when and what to start for the Hepatitis B coinfected patient will be discussed, including the management of the patient who fails initial therapy. Diagnostic and monitoring guidelines will be discussed for the Hepatitis C infected patient including implementing Hepatitis C treatment within the scope of our general HIV practices.
(Handouts)

Management of the ARV-experienced Patient
Todd S. Wills, MD
Management of antiretroviral patient presents challenges to even the most experienced HIV care providers. The speaker will review the important points when considering a regimen change. The session will place specific emphasis on virologic goals of second, third, and later regimens in the setting of newer antiretroviral agents and classes. Case vignettes will be used to illustrate the decision-making process.
(Handouts)

HIV Jeopardy
Ron Wilcox, MD
HIV Jeopardy is an interactive session developed as a review of key points from presentations given throughout the Fundamentals Track. The audience will participate as part of teams or observers.

Risk Screening: Behavioral Risks and STDs
John F. Toney, MD
Most HIV care providers do not routinely ask their patients about ongoing HIV transmission risk. Sexually transmitted infections are encountered frequently in many HIV-positive patients, especially MSM, reinforcing the observation that people with HIV may continue to participate in behaviors known to facilitate HIV transmission. Additionally, STI screening in persons with HIV remains infrequent. By recognizing that STI screening in addition to brief counseling sessions and short prevention messages may affect patient behavior, the care setting can serve as a means of curbing HIV transmission in the U.S. This presentation, the first of four modules provided by the National Network of STD/HIV Prevention Training Centers, will help clinicians better incorporate HIV prevention into the medical care of persons living with HIV.
(Handouts)